Here, we presented SCF-based drug conjugate, SCF-DM1 showed inhibitory activity (IC50 < 30 nM) towards KIT-mutated GIST cells in vitro and showed inhibitory effect against imatinib-resistant GIST 430 cells in a mouse model. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.